加藤 悠太郎

Medicine & Life Sciences

1. Liver 100%
2. Hepatic Veins 60%
3. Hepatocellular Carcinoma 43%
4. Capsules 42%
5. Propensity Score 41%
6. Pancreatectomy 31%
7. Segmental Mastectomy 31%
8. Neoplasms 28%
9. Pancreatic Neoplasms 26%
10. Gastrectomy 24%
11. Drug Therapy 23%
12. Minimally Invasive Surgical Procedures 22%
13. atezolizumab 21%
14. Dissection 20%
15. Robotics 20%
16. Anatomy 20%
17. Neoplasm Metastasis 19%
18. Abdomen 18%
19. Margins of Excision 16%
20. Living Donors 15%
21. Bevacizumab 14%
22. Hepatectomy 14%
23. Stomach Ulcer 14%
24. Lymph Node Excision 13%
25. Systematic Reviews 12%
26. Surgeons 12%
27. Liver Transplantation 12%
28. Gastroenterostomy 12%
29. Stomach Neoplasms 11%
30. Transplants 11%
31. Laparoscopic Cholecystectomy 11%
32. Adenocarcinoma 11%
33. Pancreaticoduodenectomy 11%
34. ramucirumab 10%
35. Perivascular Epithelioid Cell Neoplasms 10%
36. Pancreas 10%
37. Maple Syrup Urine Disease 10%
38. Observational Studies 10%
39. alpha-Fetoproteins 10%
40. Bilirubin 10%
41. Portal Vein 9%
42. Pancreaticojejunostomy 9%
43. Liver Cell Adenoma 9%
44. Gallbladder 9%
45. Retrospective Studies 9%
46. Recurrence 9%
47. Klatskin Tumor 9%
48. Biliary Tract Neoplasms 9%
49. Arterial Switch Operation 9%
50. Anus Neoplasms 9%